DLA PIPER LLP (US)

Lobbying for PRELUDE CORPORATION (PRELUDEDX) · Precision cancer diagnostics company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $70,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Medicare/Medicaid

Policies related to Medicare reimbursement for cancer diagnostics.

Health Issues

Improved patient access to cancer screening diagnostics.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.